Akero Therapeutics Inc buy Wolfe Research
Start price
11.06.24
/
50%
€21.31
Target price
11.06.25
-
Performance (%)
-2.72%
Price
28.06.24
€21.89
Summary
This prediction is currently active. With a performance of -2.72%, the BUY prediction for Akero Therapeutics Inc by Wolfe_Research is down slightly. This prediction currently runs until 11.06.25. The prediction end date can be changed by Wolfe_Research at any time. Wolfe_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Akero Therapeutics Inc | 0.969% |
| iShares Core DAX® | 1.175% |
| iShares Nasdaq 100 | 1.232% |
| iShares Nikkei 225® | 1.563% |
| iShares S&P 500 | 0.034% |
Comments by Wolfe_Research for this prediction
In the thread Akero Therapeutics Inc diskutieren
Akero Therapeutics, Inc. (NASDAQ: AKRO) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.
Ratings data for AKRO provided by MarketBeat